1. 主頁
  2. 研究焦點

健康與藥物研發

CMP

 

此研究領域致力改革健康與福祉。香港浸會大學的研究學者融合中醫藥哲學、化學生物學、數據分析、以及環境、物理與社會科學等尖端科學，突破學術界限。大學已準備就緒，為人類疾病的預防措施、診斷技術和治療方法提供革命性的改變，以促進健康、推動繁榮、改變生活、振奮人心之旅。

研究亮點

1

NAD capping of RNAs: mechanisms and functions 

1

Stiffness in nonlinear brain connectome: Identifying effective strategies for modulating neurocognition and treating neuropsychiatric disorders

 

1

From target understandings of sclerostin to therapeutic aptamer drug discovery

1

Development of a new therapeutic inhibitor for nasopharyngeal carcinoma 

 

1

Resource utilisation and environmental impact mitigation of plastic waste

1

Transformative development of multimodal functional metabolomics strategies for translational medicine innovation

1

New regulatory mechanism for insulin resistance and therapeutic target for age-related diabetes 

1

Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis 

 

1

New regulatory mechanism of satiety and therapeutic target for obesity 

1

Application of polysaccharide as chemical marker in quality control of saccharide-dominant Chinese medicines: cordyceps sinensis, a case study

 

1

Impairment of autophagy-lysosomal pathway in Parkinson's disease: Novel roles of HMGB1-TFEB interplay and therapeutic implication of Chinese medicine compounds 

1

Rapid antimicrobial susceptibility testing for precision therapy of bacterial infection 

 

1

Elucidating the role of TLR4/STAT3 signaling in the antimelanoma effects of atractylenolide II

1

Exploration of Justicia plants as innovative antimicrobial solutions against highly pathogenic avian influenza virus (HPAIV) for veterinary and human health

1

CDD-2101: Novel Chinese medicine for the treatment of chronic constipation authorized by U.S. FDA for clinical trial

1

CDD-2103: A self-developed Chinese medicine for the treatment of Ulcerative Colitis approved by National Medical Products Administration for clinical trial 

 

1

CDD-2107: Hong Kong's first botanical drug granted FDA orphan drug designation for the treatment of BAG3-related myofibrillar myopathy (Bag3opathy)

1

Elevating chronic disease care: Communication interventions to enhance symptom management in patients with irritable bowel disease

 

1

Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis

1

Statistics did not prove that the Huanan Seafood Wholesale Market was the early epicentre of the COVID-19 pandemic

 

1

New cell entry mechanism of SARS-CoV-2 and therapeutic target for COVID-19

1

Molecular understanding and drug discovery on the complex interaction between obesity and cancer guided by holistic view of TCM

領域研究中心